Compare SKLZ & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKLZ | ELUT |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 46.5M |
| IPO Year | 2020 | 2020 |
| Metric | SKLZ | ELUT |
|---|---|---|
| Price | $2.87 | $1.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $6.00 |
| AVG Volume (30 Days) | 34.6K | ★ 171.3K |
| Earning Date | 05-07-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.98 | ★ 146.77 |
| EPS | N/A | ★ 0.87 |
| Revenue | ★ $92,865,000.00 | $12,293,000.00 |
| Revenue This Year | $13.33 | N/A |
| Revenue Next Year | $12.68 | $10.83 |
| P/E Ratio | ★ N/A | $1.22 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.10 | $0.50 |
| 52 Week High | $9.11 | $2.99 |
| Indicator | SKLZ | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 36.99 | 51.40 |
| Support Level | N/A | $0.89 |
| Resistance Level | $3.68 | $1.15 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 0.00 | 26.25 |
Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. The company's reportable business segments are: the Skillz segment and the Aarki segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is an artificial intelligence company that delivers advertising solutions. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The majority of its revenue is generated from the Skillz segment. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.